bibliographic entry 8105549 [be/8105549]
https://w3id.org/oc/corpus/be/8105549

is a

• bibliographic reference

content

• Ludwig H, Kasparu H, Leitgeb C, Rauch E, Linkesch W, Zojer N et al. Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma. Blood 2014; 123: 985–991. PMID: 24227817

references

• https://w3id.org/oc/corpus/br/334685